Information Collection

Registration for the NCI Workshop on Rational Drug Discovery (NCI)

IC 249007 under ICR 202010-0925-003 · OMB 0925-0740.

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0925-0740 can be found here:

Documents and Forms

Documents and forms in this information collection
Document Name	Document Type
Form 1 Registration form screenshot Registration for the NCI Workshop on Rational Drug Discovery (NCI)	Form
1 Registration form screenshot Registration Screenshot Workshop for Rational Drug Discovery.pdf	Form
Email Advertisement RDD.pdf email	IC Document
Sub-Study NCI Rationale Drug Discovery Workshop.docx Registration for the NCI Workshop on Rational Drug Discovery	IC Document

IC Title:

Registration for the NCI Workshop on Rational Drug Discovery (NCI)

Agency IC Tracking Number:

IC Status: New

Obligation to Respond: Voluntary

CFR Citation:

Information Collection Instruments:

table that charts list of instruments
Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Form	1				Yes	Yes	Fillable Fileable

Line of Business: Health

Subfunction: Health Care Services

Privacy Act System of Records

Title:

FR Citation:

Number of Respondents: 500

Number of Respondents for Small Entity: 0

Affected Public: Individuals or Households

Percentage of Respondents Reporting Electronically: 100 %

table that charts list of burden
	Approved	Program Change Due to Agency Discretion
Annual Number of Responses for this IC	500	500
Annual IC Time Burden (Hours)	42	42
Annual IC Cost Burden (Dollars)	0	0

Documents for IC

table that charts IC Documents
Title	Document	Date Uploaded
email		08/25/2021
Registration for the NCI Workshop on Rational Drug Discovery		08/25/2021

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

Something went wrong when downloading this file. If you have any questions, please send an email to [email protected].